Chemotherapy is not mustard gas, but the two share a direct historical and chemical connection. The earliest chemotherapy drug, nitrogen mustard, was derived from the same class of compounds as the sulfur mustard used as a chemical weapon in World War I. That origin story is not a myth or an oversimplification. The first cancer patient ever treated with chemotherapy received an intravenous nitrogen mustard compound at Yale in 1942, and several drugs in this family remain in clinical use today.
How a Chemical Weapon Led to Cancer Treatment
After World War I, medical researchers noticed that soldiers exposed to mustard gas suffered severe damage to their lymphatic tissue and bone marrow. The gas was destroying white blood cells at an alarming rate. That observation raised a question: if mustard gas could wipe out healthy white blood cells, could a related compound kill cancerous ones?
During World War II, the U.S. military quietly funded research at Yale School of Medicine to explore this idea. Pharmacologists Alfred Gilman and Louis Goodman, working under a classified military contract, began testing nitrogen mustard on rabbits and confirmed it dramatically reduced white blood cell counts. They then moved to mice with transplanted lymphomas, where the compound shrank tumors. Convinced it could work in humans, they brought their results to surgeon Gustaf Lindskog.
On August 27, 1942, a 48-year-old man with terminal lymphosarcoma became the first person in history to receive chemotherapy. Radiation had stopped working, and he had no remaining treatment options. He was given 10 daily intravenous doses of nitrogen mustard. Because no one had any idea how much to give, his dose ended up being roughly 2.5 times what later became the standard amount. Within two days his tumors softened, and by the end of treatment they had disappeared. The remission was temporary, but the principle was proven: chemicals could fight cancer.
What Nitrogen Mustard and Mustard Gas Have in Common
Sulfur mustard (the chemical weapon) and nitrogen mustard (the cancer drug) belong to the same family of compounds. They share a similar molecular backbone built around chloroethyl groups, which are the reactive parts that do the biological damage. The key structural difference is that sulfur mustard has a sulfur atom at its center, while nitrogen mustard swaps in a nitrogen atom. That single change alters the compound’s behavior enough to make it useful in medicine, though it remains highly toxic.
Both versions work by forming highly reactive ring-shaped ions when they encounter water or biological fluids. These ions latch onto DNA, RNA, and proteins inside cells. When they bind to DNA, they can link the two strands of the double helix together, creating what chemists call a crosslink. A cell with crosslinked DNA cannot copy itself properly, so it dies. This is why mustard gas destroys tissue on contact, and it is also, in a controlled setting, why nitrogen mustard kills cancer cells.
How the Drug Differs From the Weapon
The difference between a chemical weapon and a chemotherapy drug comes down to form, dose, and delivery. Sulfur mustard is inhaled or absorbed through the skin in uncontrolled amounts during warfare, causing widespread blistering, lung damage, and bone marrow destruction. Nitrogen mustard in a medical setting is a purified, precisely dosed compound delivered intravenously or applied topically to the skin, targeting cells that divide rapidly.
Cancer cells divide faster than most healthy cells, which makes them more vulnerable to DNA-damaging agents. By carefully controlling the dose, oncologists can destroy a significant portion of cancer cells while limiting (though not eliminating) harm to normal tissue. The first patient at Yale received a dose calculated from rabbit toxicology studies at 0.1 mg per kilogram of body weight. That level of precision is the opposite of battlefield exposure, where the goal is indiscriminate destruction.
That said, nitrogen mustard drugs are classified as vesicants, meaning they cause blistering if they leak out of a vein during infusion or contact the skin in concentrated form. This is the same property that makes mustard gas a weapon. Healthcare workers handle these drugs with strict protective protocols for exactly this reason.
Nitrogen Mustard Drugs Still Used Today
The original nitrogen mustard compound, mechlorethamine (sold under the brand name Mustargen), is still available. Its most common modern application is as a topical gel for mycosis fungoides, a rare type of skin lymphoma. The European Medicines Agency has approved the gel formulation for early-stage disease, where it is applied directly to skin lesions rather than given intravenously.
More importantly, nitrogen mustard spawned an entire class of chemotherapy drugs called alkylating agents, several of which remain frontline cancer treatments more than 70 years later:
- Cyclophosphamide is one of the most widely used chemotherapy drugs in the world. It treats malignant lymphoma, acute lymphoblastic leukemia, multiple myeloma, breast cancer, ovarian cancer, lung cancer, and neuroblastoma, among others.
- Chlorambucil is used for chronic lymphocytic leukemia, Hodgkin’s disease, ovarian cancer, and certain lymphomas.
- Melphalan treats multiple myeloma, ovarian cancer, and breast cancer.
- Bendamustine is a newer nitrogen mustard derivative approved for certain blood cancers.
These drugs all share the same core mechanism: they damage DNA by attaching chemical groups to it, preventing cancer cells from replicating. Each one modifies the original nitrogen mustard structure to improve how the body absorbs and processes it, to target specific tissues more effectively, or to reduce certain side effects.
Why These Drugs Cause Side Effects
Nitrogen mustard compounds do not distinguish perfectly between cancer cells and healthy ones. They attack any rapidly dividing cell, which is why chemotherapy with alkylating agents commonly causes hair loss, nausea, and drops in blood cell counts. The bone marrow suppression that made mustard gas so devastating to soldiers is the same effect oncologists monitor carefully during treatment.
Nitrogen mustards also damage DNA in healthy cells, which means they are themselves capable of causing mutations. This is not theoretical. These drugs are genotoxic in virtually every laboratory test, producing a wide range of DNA mutations including base substitutions, deletions, and chromosomal rearrangements. In practical terms, this means that alkylating agent chemotherapy carries a small but real long-term risk of causing secondary cancers, particularly blood cancers, years after treatment. Oncologists weigh this risk against the immediate threat of the cancer being treated.
The Bottom Line on the Connection
Chemotherapy is not mustard gas poured into a vein. But the first chemotherapy drug was a direct chemical relative of mustard gas, developed by military-funded researchers who noticed that a weapon’s most destructive property, killing rapidly dividing cells, could be turned against cancer. Several drugs in this family remain among the most important cancer treatments available, treating everything from lymphoma to breast cancer to multiple myeloma. The connection between chemical warfare and cancer medicine is real, well-documented, and one of the stranger turns in the history of modern medicine.